Tus kws kho mob
QP65-20 Commercial Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) Criteria: Satralizumab
Hnub Tim pib siv tau lub khoos kas: Lub Xya Hli Ntuj Tim 22, 2020
Tshawb Nrhiav
Nthuav pom cov txiaj ntsig tshwm sim 1931 - 1940 ntawm 4303
Tus kws kho mob
P48-20 CMS Issued Prior Authorization Requirements for Certain Hospital Outpatient Department (OPD) Services – Effective July 1, 2020
Hnub Tim pib siv tau lub khoos kas: Lub Xya Hli Ntuj Tim 01, 2020
Tus kws kho mob
2020 July Bulletins
Hnub Tim pib siv tau lub khoos kas: Lub Xya Hli Ntuj Tim 01, 2020
Tus kws kho mob
QP61-20 Signify Health Virtual Visits for Medicare Advantage and SecureBlue Members
Hnub Tim pib siv tau lub khoos kas: Lub Xya Hli Ntuj Tim 08, 2020
Tus kws kho mob
QP58-20 Commercial Pharmacy Benefit Exclusion for Medical Drugs Anjeso™ , Fetroja™ and Potassium Phosphates
Hnub Tim pib siv tau lub khoos kas: Lub Xya Hli Ntuj Tim 08, 2020
Tus kws kho mob
QP59-20 MHCP Pharmacy Benefit Exclusion for DurystaTM and Fensolvi®
Hnub Tim pib siv tau lub khoos kas: Lub Xya Hli Ntuj Tim 08, 2020
Tus kws kho mob
QP60-20 Commercial Pharmacy Benefit Exclusion for Procysbi® Delayed-Release Granules
Hnub Tim pib siv tau lub khoos kas: Lub Xya Hli Ntuj Tim 08, 2020
Tus kws kho mob
P51-20 Updated Minnesota Health Care Programs and Minnesota Senior Health Options (MSHO) Prior Authorization and Medical Policy Requirements
Hnub Tim pib siv tau lub khoos kas: Lub Xya Hli Ntuj Tim 01, 2020
Tus kws kho mob
P47-20 New Medical, Medical Drug and Behavioral Health Policy Management Updates—Effective August 31, 2020
Hnub Tim pib siv tau lub khoos kas: Lub Xya Hli Ntuj Tim 01, 2020
Tus kws kho mob
P50-20 eviCore is Changing Prior Authorization Guidelines used to Review Durable Medical Equipment (DME), Home Health Care (HHC), and Post-Acute Care (PAC) Services for Medicare Advantage Subscribers
Hnub Tim pib siv tau lub khoos kas: Lub Xya Hli Ntuj Tim 01, 2020